Ambiq Micro, Inc.
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
AMBQ$45.24-1.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders’ Equity
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)
For the three and nine months ended September 30, 2025 and 2024
(Unaudited and in thousands, except share amounts)
| Redeemable ConvertiblePreferred Stock · Common Stock · AdditionalPaid- · Accumulated · AccumulatedOtherComprehensive · TotalStockholders’ | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | In-Capital | Deficit | Income (Loss) | Equity (Deficit) | |
| Balance June 30, 2024 | 334,307,317 | 371,657 | 372,686 | — | 24,517 | (300,316) | (788) | $(276,587) |
| Issuance of Series G preferred shares, net of offering costs of $14 | 7,188,841 | 6,487 | — | — | — | — | — | — |
| Exercise of stock options | — | — | 2,685 | — | 56 | — | — | 56 |
| Stock-based compensation | — | — | — | — | 2,122 | — | — | 2,122 |
| Deemed dividend | — | — | — | — | 305 | (305) | — | — |
| Currency translation adjustment | — | — | — | — | — | — | 56 | $56 |
| Net loss | — | — | — | — | — | (9,438) | — | (9,438) |
| Balance September 30, 2024 | 341,496,158 | $378,144 | 375,371 | $— | $27,000 | $(310,059) | $(732) | $(283,791) |
| Balance June 30, 2025 | 341,496,158 | 378,150 | 450,682 | — | 30,159 | (337,030) | (440) | $(307,311) |
| Conversion of redeemable convertible preferred stock into commmon stock in connection with initial public offering | (341,496,158) | (378,150) | 12,729,240 | — | 378,150 | — | — | 378,150 |
| Issuance of common stock in connection with initial public offering, net of offering costs, underwriting discounts and commissions | — | — | 4,600,000 | — | 99,843 | — | — | 99,843 |
| Settlement of warrant liability | — | — | — | — | 173 | — | — | 173 |
| Exercise of warrants | — | — | 435,013 | — | 5,702 | — | — | 5,702 |
| Exercise of stock options | — | — | 23,527 | — | 178 | — | — | 178 |
| Stock-based compensation | — | — | — | — | 2,068 | — | — | 2,068 |
| Currency translation adjustment | — | — | — | — | — | — | (14) | (14) |
| Net loss | — | — | — | — | — | (9,002) | — | (9,002) |
| Balance September 30, 2025 | — | $— | 18,238,462 | $— | $516,273 | $(346,032) | $(454) | $169,787 |
| Redeemable ConvertiblePreferred Stock · Common Stock · AdditionalPaid- · Accumulated · AccumulatedOtherComprehensive · TotalStockholders’ | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | In-Capital | Deficit | Income (Loss) | Equity (Deficit) | |
| Balance January 1, 2024 | 277,238,979 | $320,161 | 356,356 | $— | $17,676 | $(277,865) | $(839) | $(261,028) |
| Issuance of Series G preferred shares, net of offering costs of $51 | 64,257,179 | 57,983 | — | — | — | — | — | — |
| Issuance of warrants | — | — | — | — | 1,940 | — | — | 1,940 |
| Exercise of stock options | — | — | 19,015 | — | 349 | — | — | 349 |
| Stock-based compensation | — | — | — | — | 4,311 | — | — | 4,311 |
| Deemed dividend | — | — | — | — | 2,724 | (2,724) | — | — |
| Currency translation adjustment | — | — | — | — | — | — | 107 | 107 |
| Net loss | — | — | — | — | — | (29,470) | — | (29,470) |
| Balance September 30, 2024 | 341,496,158 | $378,144 | 375,371 | $— | $27,000 | $(310,059) | $(732) | $(283,791) |
| Balance January 1, 2025 | 341,496,158 | $378,150 | 434,720 | $— | $28,368 | $(320,250) | $(520) | $(292,402) |
| Conversion of redeemable convertible preferred stock into commmon stock in connection with initial public offering | (341,496,158) | (378,150) | 12,729,240 | — | 378,150 | — | — | 378,150 |
| Issuance of common stock in connection with initial public offering, net of offering costs, underwriting discounts and commissions | — | — | 4,600,000 | — | 99,843 | — | — | 99,843 |
| Settlement of warrant liability | — | — | — | — | 173 | — | — | 173 |
| Exercise of warrants | — | — | 435,013 | — | 5,702 | — | — | 5,702 |
| Exercise of stock options | — | — | 39,489 | — | 353 | — | — | 353 |
| Stock-based compensation | — | — | — | — | 3,684 | — | — | 3,684 |
| Currency translation adjustment | — | — | — | — | — | — | 66 | 66 |
| Net loss | — | — | — | — | — | (25,782) | — | (25,782) |
| Balance September 30, 2025 | — | $— | 18,238,462 | $— | $516,273 | $(346,032) | $(454) | $169,787 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.